Evolent Health Overview
Evolent Health Target Price
Analysts' 12-month price predictions for EVH.
Get informed when a big investor buys or sells
+ FollowShare Price
$4.8
Average Target Price
$5.17
7.6% upside
7.6% upside3 analysts in the last 4 months
High: $6 | Low: $3.5
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2026-05-12 | Canaccord Genuity | $6 | 25% upside |  |
| 2026-02-25 | Truist Financial | $6 | 25% upside | |
| 2026-02-25 | BMO CapitalSean Dodge | $3.5 |  27.1% downside | |
| 2026-02-02 | BTIGDavid Larsen | $10 | 108.3% upside | |
| 2025-12-02 | Piper Sandler | $6 | 25% upside | |
| 2025-01-16 | UBSKevin Caliendo | $14 | 191.7% upside | |
| 2025-01-15 | Truist FinancialJailendra Singh | $20 | 316.7% upside | |
| 2025-01-14 | RBC CapitalSean Dodge | $17 | 254.2% upside | |
| 2025-01-10 | JMP SecuritiesConstantine Davides | $18 | 275% upside | |
| 2024-11-18 | OppenheimerMohan Naidu | $28 | 483.3% upside | |
| 2024-10-17 | StephensJeff Garro | $38 | 691.7% upside | |
| 2024-08-09 | Truist FinancialJailendra Singh | $33 | 587.5% upside | |
| 2024-06-05 | RBC CapitalSean Dodge | $42 | 775% upside | |
| 2024-05-14 | Truist FinancialJailendra Singh | $28 | 483.3% upside | |
| 2024-04-17 | Piper SandlerJessica Tassan | $51 | 962.5% upside | |
| 2024-03-28 | Canaccord GenuityRichard Close | $44 | 816.7% upside | |
| 2022-08-03 | BTIG | $50 | 941.7% upside | |
| 2022-05-09 | Canaccord Genuity | $45 | 837.5% upside | |